CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CXCL16-positive dendritic cells enhance invariant natural killer T cell-dependent IFNγ production and tumor control
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 6, Pages e1160979
Publisher
Informa UK Limited
Online
2016-04-23
DOI
10.1080/2162402x.2016.1160979
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival
- (2015) Sigurd M. Hald et al. BMC CANCER
- Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
- (2015) F Caiazza et al. BRITISH JOURNAL OF CANCER
- Reconstitution models to evaluate natural killer T cell function in tumor control
- (2015) Simon Gebremeskel et al. IMMUNOLOGY AND CELL BIOLOGY
- Regulation of NKT Cell Localization in Homeostasis and Infection
- (2015) Drew Slauenwhite et al. Frontiers in Immunology
- Natural killer T cell activation overcomes immunosuppression to enhance clearance of postsurgical breast cancer metastasis in mice
- (2015) Simon Gebremeskel et al. OncoImmunology
- Tumor-conditioned Gr-1+CD11b+ myeloid cells induce angiogenesis through the synergistic action of CCL2 and CXCL16 in vitro
- (2014) Eun Chun Han et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity
- (2014) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- A Single Subset of Dendritic Cells Controls the Cytokine Bias of Natural Killer T Cell Responses to Diverse Glycolipid Antigens
- (2014) Pooja Arora et al. IMMUNITY
- The reversible P2Y12 inhibitor ticagrelor inhibits metastasis and improves survival in mouse models of cancer
- (2014) Simon Gebremeskel et al. INTERNATIONAL JOURNAL OF CANCER
- Radiation-Induced CXCL16 Release by Breast Cancer Cells Attracts Effector T Cells
- (2014) S. Matsumura et al. JOURNAL OF IMMUNOLOGY
- Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells
- (2014) E. Germanov et al. JOURNAL OF IMMUNOLOGY
- ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion
- (2014) Rosaria Gangemi et al. Pigment Cell & Melanoma Research
- Regulation of Cytokine Polarization and T Cell Recruitment to Inflamed Paws in Mouse Collagen-Induced Arthritis by the Chemokine Receptor CXCR6
- (2014) Drew Slauenwhite et al. Arthritis & Rheumatology
- Evidence That CXCL16 Is a Potent Mediator of Angiogenesis and Is Involved in Endothelial Progenitor Cell Chemotaxis: Studies in Mice With K/BxN Serum-Induced Arthritis
- (2013) Takeo Isozaki et al. ARTHRITIS AND RHEUMATISM
- Invariant NKT cell activation induces neutrophil accumulation and hepatitis: Opposite regulation by IL-4 and IFN-γ
- (2013) Hua Wang et al. HEPATOLOGY
- Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells
- (2013) You Jeong Lee et al. NATURE IMMUNOLOGY
- Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cells
- (2013) X. Wen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Role of T Cells in -Galactosylceramide-Mediated Immunity
- (2012) C. Paget et al. JOURNAL OF IMMUNOLOGY
- Invariant natural killer T cells as sensors and managers of inflammation
- (2012) Luc Van Kaer et al. TRENDS IN IMMUNOLOGY
- Soluble CXCL16 in Preoperative Serum is a Novel Prognostic Marker and Predicts Recurrence of Liver Metastases in Colorectal Cancer Patients
- (2011) Kohei Matsushita et al. ANNALS OF SURGICAL ONCOLOGY
- IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN- Production
- (2011) A. C. Jaime-Ramirez et al. JOURNAL OF IMMUNOLOGY
- Induction of NKT cell-specific immune responses in cancer tissues after NKT cell-targeted adoptive immunotherapy
- (2010) Kazuki Yamasaki et al. CLINICAL IMMUNOLOGY
- An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells
- (2010) Robbert van der Voort et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Critical role for the chemokine receptor CXCR6 in NK cell–mediated antigen-specific memory of haptens and viruses
- (2010) Silke Paust et al. NATURE IMMUNOLOGY
- Combination therapy ofin vitro-expanded natural killer T cells and α-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma
- (2009) Naoki Kunii et al. CANCER SCIENCE
- Enhanced Tumor Metastasis in Response to Blockade of the Chemokine Receptor CXCR6 Is Overcome by NKT Cell Activation
- (2009) R. Cullen et al. JOURNAL OF IMMUNOLOGY
- A Phase I-II Study of -Galactosylceramide-Pulsed IL-2/GM-CSF-Cultured Peripheral Blood Mononuclear Cells in Patients with Advanced and Recurrent Non-Small Cell Lung Cancer
- (2009) S. Motohashi et al. JOURNAL OF IMMUNOLOGY
- The Chemokine CXCL16 and Its Receptor, CXCR6, as Markers and Promoters of Inflammation-Associated Cancers
- (2009) Merav Darash-Yahana et al. PLoS One
- Regulation of CXCL16 expression and secretion by myeloid cells is not altered in rheumatoid arthritis
- (2008) A W T van Lieshout et al. ANNALS OF THE RHEUMATIC DISEASES
- CXCR6 Induces Prostate Cancer Progression by the AKT/Mammalian Target of Rapamycin Signaling Pathway
- (2008) J. Wang et al. CANCER RESEARCH
- Tumoural CXCL16 expression is a novel prognostic marker of longer survival times in renal cell cancer patients
- (2008) Paul Gutwein et al. EUROPEAN JOURNAL OF CANCER
- Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1- NKT cell population
- (2008) J. M. Coquet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started